Trump claims that autism is caused by Tylenol use during pregnancy, advises to “fight like hell not to take it”

Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature”

FDA has initiated the approval of leucovorin calcium tablets, rushing them to market as part of a push from the Trump administration to identify potential treatments for autism spectrum disorder.

September 26, 2025

Vol.51 No.35

By Claire Marie Porter and Paul Goldberg

Cancer Policy

Bhattacharya: New grant review criterion is “not political”

NIH’s new “unified grant funding policy,” is “not political,” NIH Director Jay Bhattacharya said during his remarks at Research!America’s annual National Health Research Forum Sept. 17.

FDA approves Keytruda Qlex injection for subcutaneous use in 38 tumor indications

FDA approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) Sept. 19 for subcutaneous injection for adult and pediatric (12 years and older) solid tumor indications approved for the intravenous formulation of pembrolizumab.

FDA grants priority review to HER2-directed therapy as first-line treatment of HER2-positive metastatic breast cancer

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been accepted and granted Priority Review in the U.S. FDA for the first-line treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.

September 26, 2025

Vol.51 No.35

NCI

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute whose research is focused on apoptosis and functional diagnostics, has been tapped by the Trump administration to become the 18th director of the National Cancer Institute.

September 25, 2025

Vol.51 No.35

By Claire Marie Porter and Paul Goldberg

Cancer Policy

AACR survey finds overwhelming public support for federal funding for medical and cancer research

The American Association for Cancer Research released the results of a national survey measuring voters’ attitudes about federal funding for medical research, which found very high levels of support for federal funding for medical and cancer research across the electorate.

September 19, 2025

Vol.51 No.34

By Claire Marie Porter

Trump claims that autism is caused by Tylenol use during pregnancy, advises to “fight like hell not to take it”

YOU MAY BE INTERESTED IN

Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature”

Bhattacharya: New grant review criterion is “not political”

FDA approves Keytruda Qlex injection for subcutaneous use in 38 tumor indications

FDA grants priority review to HER2-directed therapy as first-line treatment of HER2-positive metastatic breast cancer

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

AACR survey finds overwhelming public support for federal funding for medical and cancer research

Renew today!

Subscriber content

Never miss an issue!

Login

Trump claims that autism is caused by Tylenol use during pregnancy, advises to “fight like hell not to take it”

YOU MAY BE INTERESTED IN

Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autismExperts call the move “extremely premature”

Bhattacharya: New grant review criterion is “not political”

FDA approves Keytruda Qlex injection for subcutaneous use in 38 tumor indications

FDA grants priority review to HER2-directed therapy as first-line treatment of HER2-positive metastatic breast cancer

Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

AACR survey finds overwhelming public support for federal funding for medical and cancer research

Never miss an issue!

Login

Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature”

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say